Esophageal Cancer

  • Brian G. Czito
  • Christopher G. Willett
Part of the Medical Radiology book series (MEDRAD)


Less than 15% of patients diagnosed with esophageal cancer are cured, with half of patients presenting with unresectable or metastatic disease. This chapter will review the natural history and treatment of esophageal cancer, including anatomy, patterns of spread and failure, staging, radiation planning techniques, toxicity data and future treatment strategies.


Positron Emission Tomography Esophageal Cancer Gastroesophageal Junction Radiation Pneumonitis Esophageal Cancer Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Aisner J, Forastiere A, Aroney R (1983) Patterns of recurrence for cancer of the lung and esophagus. Cancer Treat Symp 2:87–105Google Scholar
  2. al-Sarraf M, Martz K, Herskovic A et al (1997) Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. J Clin Oncol 15:277–284PubMedGoogle Scholar
  3. American Cancer Society (2005) Cancer facts and figures- 2005. In Society AC (ed) Edition Atlanta.Google Scholar
  4. American Joint Committee on Cancer (2010) Esophagus. Springer, New YorkGoogle Scholar
  5. Anderson LL, Lad TE (1982) Autopsy findings in squamous-cell carcinoma of the esophagus. Cancer 50:1587–1590PubMedCrossRefGoogle Scholar
  6. Araujo CM, Souhami L, Gil RA et al (1991) A randomized trial comparing radiation therapy versus concomitant radiation therapy and chemotherapy in carcinoma of the thoracic esophagus. Cancer 67:2258–2261PubMedCrossRefGoogle Scholar
  7. Arnott SJ, Duncan W, Gignoux M et al (2005) Preoperative radiotherapy for esophageal carcinoma. Cochrane Database Syst Rev CD001799Google Scholar
  8. Asakura H, Hashimoto T, Zenda S et al (2010) Analysis of dose-volume histogram parameters for radiation pneumonitis after definitive concurrent chemoradiotherapy for esophageal cancer. Radiother Oncol 95:240–244Google Scholar
  9. Baquet CR, Commiskey P, Mack K et al (2005) Esophageal cancer epidemiology in blacks and whites: racial and gender disparities in incidence, mortality, survival rates and histology. J Natl Med Assoc 97:1471–1478PubMedGoogle Scholar
  10. Beatty JD, DeBoer G, Rider WD (1979) Carcinoma of the esophagus: pretreatment assessment, correlation of radiation treatment parameters with survival, and identification and management of radiation treatment failure. Cancer 43:2254–2267PubMedCrossRefGoogle Scholar
  11. Bedenne L, Michel P, Bouche O et al (2007) Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol 25:1160–1168PubMedCrossRefGoogle Scholar
  12. Beseth BD, Bedford R, Isacoff WH et al (2000) Endoscopic ultrasound does not accurately assess pathologic stage of esophageal cancer after neoadjuvant chemoradiotherapy. Am Surg 66:827–831PubMedGoogle Scholar
  13. Blackstock AW, Farmer MR, Lovato J et al (2006) A prospective evaluation of the impact of 18-F-fluoro-deoxy-D-glucose positron emission tomography staging on survival for patients with locally advanced esophageal cancer. Int J Radiat Oncol Biol Phys 64:455–460PubMedCrossRefGoogle Scholar
  14. Bloedorn F, Kasdorf H (1971) Radiotherapy in squamous cell carcinoma of the esophagus. Chicago: Year Book Medical Google Scholar
  15. Bosset JF, Gignoux M, Triboulet JP et al (1997) Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 337:161–167PubMedCrossRefGoogle Scholar
  16. Brown LM, Swanson CA, Gridley G et al (1995) Adenocarcinoma of the esophagus: role of obesity and diet. J Natl Cancer Inst 87:104–109PubMedCrossRefGoogle Scholar
  17. Burmeister BH, Dickie G, Smithers BM et al (2000) Thirty-four patients with carcinoma of the cervical esophagus treated with chemoradiation therapy. Arch Otolaryngol Head Neck Surg 126:205–208PubMedGoogle Scholar
  18. Burmeister BH, Smithers BM, Gebski V et al (2005) Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. Lancet Oncol 6:659–668PubMedCrossRefGoogle Scholar
  19. Cohen RJ, Paskalev K, Litwin S et al (2010) Esophageal motion during radiotherapy: quantification and margin implications. Dis Esophagus 23:473–479PubMedCrossRefGoogle Scholar
  20. Coia LR, Engstrom PF, Paul AR et al (1991) Long-term results of infusional 5-FU, mitomycin-C and radiation as primary management of esophageal carcinoma. Int J Radiat Oncol Biol Phys 20:29–36PubMedCrossRefGoogle Scholar
  21. Coia LR, Soffen EM, Schultheiss TE et al (1993) Swallowing function in patients with esophageal cancer treated with concurrent radiation and chemotherapy. Cancer 71:281–286PubMedCrossRefGoogle Scholar
  22. Cooper JS, Guo MD, Herskovic A et al (1999) Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85–01). Radiation Therapy Oncology Group. JAMA 281:1623–1627PubMedCrossRefGoogle Scholar
  23. Cosset JM, Henry-Amar M, Pellae-Cosset B et al (1991) Pericarditis and myocardial infarctions after Hodgkin’s disease therapy. Int J Radiat Oncol Biol Phys 21:447–449PubMedCrossRefGoogle Scholar
  24. Cunningham D, Allum WH, Stenning SP et al (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355:11–20PubMedCrossRefGoogle Scholar
  25. Dahn D, Martell J, Vorwerk H et al (2009) Influence of irradiated lung volumes on perioperative morbidity and mortality in patients after neoadjuvant radiochemotherapy for esophageal cancer. Int J Radiat Oncol Biol Phys 77:44–52Google Scholar
  26. Dormans E (1939) Das Oesophaguscarcinoma: Ergebnisse der unter Mitarbet von 29 patholgischem Instituten Deutschlands Durchgefuhrten Erhebung uber das Oesophaguscarcinomon (1925–1933). Z Krebforsch 49:86CrossRefGoogle Scholar
  27. Dresner SM, Lamb PJ, Bennett MK et al (2001) The pattern of metastatic lymph node dissemination from adenocarcinoma of the esophagogastric junction. Surgery 129:103–109PubMedCrossRefGoogle Scholar
  28. Fenkell L, Kaminsky I, Breen S et al (2008) Dosimetric comparison of IMRT vs. 3D conformal radiotherapy in the treatment of cancer of the cervical esophagus. Radiother Oncol 89:287–291PubMedCrossRefGoogle Scholar
  29. Flamen P, Lerut A, Van Cutsem E et al (2000) Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. J Clin Oncol 18:3202–3210PubMedGoogle Scholar
  30. Fok M, Sham JS, Choy D et al (1993) Postoperative radiotherapy for carcinoma of the esophagus: a prospective, randomized controlled study. Surgery 113:138–147PubMedGoogle Scholar
  31. Gaast A, van Hagen P, Hulshof M (2010) Effect of preoperative concurrent chemoradiotherapy on survival of patients with resectable esophageal or esophagogastric junction cancer: Results from a multicenter randomized phase III study. J Clin Oncol 28:302sCrossRefGoogle Scholar
  32. Gao XS, Qiao X, Wu F et al (2007) Pathological analysis of clinical target volume margin for radiotherapy in patients with esophageal and gastroesophageal junction carcinoma. Int J Radiat Oncol Biol Phys 67:389–396PubMedCrossRefGoogle Scholar
  33. Gaspar LE, Nag S, Herskovic A et al (1997) American Brachytherapy Society (ABS) consensus guidelines for brachytherapy of esophageal cancer. Clinical Research Committee, American Brachytherapy Society, Philadelphia, PA. Int J Radiat Oncol Biol Phys 38:127–132PubMedCrossRefGoogle Scholar
  34. Gaspar LE, Winter K, Kocha WI et al (2000) A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207): final report. Cancer 88:988–995PubMedCrossRefGoogle Scholar
  35. Gayed IW, Liu H, Yusuf SW et al (2006) The prevalence of myocardial ischemia after concurrent chemoradiation therapy as detected by gated myocardial perfusion imaging in patients with esophageal cancer. J Nucl Med 47:1756–1762PubMedGoogle Scholar
  36. Gebski V, Burmeister B, Smithers BM et al (2007) Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol 8:226–234PubMedCrossRefGoogle Scholar
  37. Gergel TJ, Leichman L, Nava HR et al (2002) Effect of concurrent radiation therapy and chemotherapy on pulmonary function in patients with esophageal cancer: dose-volume histogram analysis. Cancer J 8:451–460PubMedCrossRefGoogle Scholar
  38. Goodner JT, Miller TP, Pack GT, Watson WL (1956) Torek esophagectomy; the case against segmental resection for esophageal cancer. J Thorac Surg 32:347–359PubMedGoogle Scholar
  39. Griffith JF, Chan AC, Chow LT et al (1999) Assessing chemotherapy response of squamous cell oesophageal carcinoma with spiral CT. Br J Radiol 72:678–684PubMedGoogle Scholar
  40. Gschossmann JM, Bonner JA, Foote RL et al (1993) Malignant tracheoesophageal fistula in patients with esophageal cancer. Cancer 72:1513–1521PubMedCrossRefGoogle Scholar
  41. Hancock SL, Donaldson SS, Hoppe RT (1993) Cardiac disease following treatment of Hodgkin’s disease in children and adolescents. J Clin Oncol 11:1208–1215PubMedGoogle Scholar
  42. Hart JP, McCurdy MR, Ezhil M et al (2008) Radiation pneumonitis: correlation of toxicity with pulmonary metabolic radiation response. Int J Radiat Oncol Biol Phys 71:967–971PubMedCrossRefGoogle Scholar
  43. Hazard L, Yang G, McAleer M (2008) Principals and techniques of radiation therapy for esphageal and gastroesophageal junction cancers. JNCCN 6:870–878PubMedGoogle Scholar
  44. Herskovic A, Martz K, al-Sarraf M et al (1992) Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326:1593–1598PubMedCrossRefGoogle Scholar
  45. Holdscher A, Bollschweiller E, Bumm R (1995) Prognostic factors of resected adenocarcinoma of the esophagus. Surgery 118:845–855CrossRefGoogle Scholar
  46. Homs MY, Steyerberg EW, Eijkenboom WM et al (2004) Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial. Lancet 364:1497–1504PubMedCrossRefGoogle Scholar
  47. Hosch SB, Stoecklein NH, Pichlmeier U et al (2001) Esophageal cancer: the mode of lymphatic tumor cell spread and its prognostic significance. J Clin Oncol 19:1970–1975PubMedGoogle Scholar
  48. Hsu FM, Lee YC, Lee JM et al (2009) Association of clinical and dosimetric factors with postoperative pulmonary complications in esophageal cancer patients receiving intensity-modulated radiation therapy and concurrent chemotherapy followed by thoracic esophagectomy. Ann Surg Oncol 16:1669–1677PubMedCrossRefGoogle Scholar
  49. Huang W, Li B, Gong H et al (2010) Pattern of lymph node metastases and its implication in radiotherapeutic clinical target volume in patients with thoracic esophageal squamous cell carcinoma: A report of 1077 cases. Radiother Oncol 95:229–233PubMedCrossRefGoogle Scholar
  50. Hulscher JB, van Sandick JW, de Boer AG et al (2002) Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 347:1662–1669PubMedCrossRefGoogle Scholar
  51. Hussey D, Barakley T, Bloedorn F. (1980) Carcinoma of the esophagus. Philadelphia: Lea & FebigerGoogle Scholar
  52. Ishikura S, Nihei K, Ohtsu A et al (2003) Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus. J Clin Oncol 21:2697–2702PubMedCrossRefGoogle Scholar
  53. Jaklitsch MT, Harpole DH Jr, Healey EA, Sugarbaker DJ (1994) Current issues in the staging of esophageal cancer. Semin Radiat Oncol 4:135–145PubMedCrossRefGoogle Scholar
  54. Kelly S, Harris KM, Berry E et al (2001) A systematic review of the staging performance of endoscopic ultrasound in gastro-oesophageal carcinoma. Gut 49:534–539PubMedCrossRefGoogle Scholar
  55. Kelsen DP, Ginsberg R, Pajak TF et al (1998) Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 339:1979–1984PubMedCrossRefGoogle Scholar
  56. Kelsen DP, Winter KA, Gunderson LL, Mortimer J, Estes NC, Haller DG, Ajani JA, Kocha W, Minsky BD, Roth JA, Willett CG, Radiation Therapy Oncology Group, USA Intergroup (2007) Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer. J Clin Oncol 25(24):3719–3725PubMedCrossRefGoogle Scholar
  57. Kole AC, Plukker JT, Nieweg OE, Vaalburg W (1998) Positron emission tomography for staging of oesophageal and gastroesophageal malignancy. Br J Cancer 78:521–527PubMedCrossRefGoogle Scholar
  58. Konski A, Doss M, Milestone B et al (2005) The integration of 18-fluoro-deoxy-glucose positron emission tomography and endoscopic ultrasound in the treatment-planning process for esophageal carcinoma. Int J Radiat Oncol Biol Phys 61:1123–1128PubMedCrossRefGoogle Scholar
  59. Laterza E, de Manzoni G, Guglielmi A et al (1999) Endoscopic ultrasonography in the staging of esophageal carcinoma after preoperative radiotherapy and chemotherapy. Ann Thorac Surg 67:1466–1469PubMedCrossRefGoogle Scholar
  60. Law SY, Fok M, Wong J (1996) Pattern of recurrence after oesophageal resection for cancer: clinical implications. Br J Surg 83:107–111PubMedCrossRefGoogle Scholar
  61. Lea JWt, Prager RL, Bender HW (1984) Jr. The questionable role of computed tomography in preoperative staging of esophageal cancer. Ann Thorac Surg 38:479–481PubMedCrossRefGoogle Scholar
  62. Lee HK, Vaporciyan AA, Cox JD et al (2003) Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma: correlation with pulmonary dose-volume histogram parameters. Int J Radiat Oncol Biol Phys 57:1317–1322PubMedCrossRefGoogle Scholar
  63. Leong T, Everitt K, al e. A prospective study to evaluate the impact of coregisted PET/CT images in radiotherpy treatment planning for esophageal cancer. Int J Radiat Oncol Biol Phys 2004; 60.Google Scholar
  64. LePrise E, Meunier B, Etienne P (1995) Sequential chemotherapy, radiotherapy for patients with squamous cell carcinoma of the esophagus. Cancer 75:2CrossRefGoogle Scholar
  65. Lightdale CJ, Kulkarni KG (2005) Role of endoscopic ultrasonography in the staging and follow-up of esophageal cancer. J Clin Oncol 23:4483–4489PubMedCrossRefGoogle Scholar
  66. Luketich JD, Friedman DM, Weigel TL et al. (1999) Evaluation of distant metastases in esophageal cancer: 100 consecutive positron emission tomography scans. Ann Thorac Surg, 68: 1133-1136; discussion 1136-1137.Google Scholar
  67. Macdonald JS, Smalley SR, Benedetti J et al (2001) Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345:725–730PubMedCrossRefGoogle Scholar
  68. Mariette C, Seitz J, Maillard E (2010) Surgery alone versus chemoradiotherapy followed by surgery for localized esophageal cancer: Analysis of a randomized controlled phase III trial FFCD 9901. J Clin Oncol 28:15sGoogle Scholar
  69. Matzinger O, Gerber E, Bernstein Z et al (2009) EORTC-ROG expert opinion: radiotherapy volume and treatment guidelines for neoadjuvant radiation of adenocarcinomas of the gastroesophageal junction and the stomach. Radiother Oncol 92:164–175PubMedCrossRefGoogle Scholar
  70. Meier I, Merkel S, Papadopoulos T et al (2008) Adenocarcinoma of the esophagogastric junction: the pattern of metastatic lymph node dissemination as a rationale for elective lymphatic target volume definition. Int J Radiat Oncol Biol Phys 70:1408–1417PubMedCrossRefGoogle Scholar
  71. Minsky B. (2007) Cancer of the Esophagus. Philadelphia: Elsevier Churchill Livingstone Google Scholar
  72. Minsky BD, Neuberg D, Kelsen DP et al (1999) Final report of Intergroup Trial 0122 (ECOG PE-289, RTOG 90–12): Phase II trial of neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 43:517–523PubMedCrossRefGoogle Scholar
  73. Minsky BD, Pajak TF, Ginsberg RJ et al (2002) INT 0123 (Radiation Therapy Oncology Group 94–05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 20:1167–1174PubMedCrossRefGoogle Scholar
  74. Moertel C (1982) The esophagus. Philadelphia: Lea & Febiger Google Scholar
  75. Monig SP, Baldus SE, Zirbes TK et al (2002) Topographical distribution of lymph node metastasis in adenocarcinoma of the gastroesophageal junction. Hepatogastroenterology 49:419–422PubMedGoogle Scholar
  76. Monjazeb AM, Riedlinger G, Aklilu M et al (2010) Outcomes of patients with esophageal cancer staged with [(1)F]fluorodeoxyglucose positron emission tomography (FDG-PET): can postchemoradiotherapy FDG-PET predict the utility of resection? J Clin Oncol 28:4714–4721Google Scholar
  77. Morota M, Gomi K, Kozuka T et al (2009) Late toxicity after definitive concurrent chemoradiotherapy for thoracic esophageal carcinoma. Int J Radiat Oncol Biol Phys 75:122–128PubMedCrossRefGoogle Scholar
  78. MRC OCWP (2002) Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomized controlled trial. Lancet Oncol 359:1727–1733Google Scholar
  79. Murakami M, Kuroda Y, Okamoto Y et al (1998) Neoadjuvant concurrent chemoradiotherapy followed by definitive high-dose radiotherapy or surgery for operable thoracic esophageal carcinoma. Int J Radiat Oncol Biol Phys 40:1049–1059PubMedCrossRefGoogle Scholar
  80. Oota K, Shin L (1977) Histological typing of gastric and oesophageal tumors. Geneva: World Healthy Organization Google Scholar
  81. Ott K, Weber W, Siewert JR (2006) The importance of PET in the diagnosis and response evaluation of esophageal cancer. Dis Esophagus 19:433–442PubMedCrossRefGoogle Scholar
  82. Picus D, Balfe DM, Koehler RE et al (1983) Computed tomography in the staging of esophageal carcinoma. Radiology 146:433–438PubMedGoogle Scholar
  83. Rankin SC, Taylor H, Cook GJ, Mason R (1998) Computed tomography and positron emission tomography in the pre-operative staging of oesophageal carcinoma. Clin Radiol 53:659–665PubMedCrossRefGoogle Scholar
  84. Rosch T (1995) Endosonographic staging of esophageal cancer: a review of literature results. Gastrointest Endosc Clin N Am 5:537–547PubMedGoogle Scholar
  85. Rosenberg J, Lichter A, Leichman L (1989) Cancer of the esophagus. JB Lippincott, PhiladelphiaGoogle Scholar
  86. Rosenberg JC, Franklin R, Steiger Z (1981) Squamous cell carcinoma of the thoracic esophagus: an interdisciplinary approach. Curr Probl Cancer 5:1–52PubMedCrossRefGoogle Scholar
  87. Roussell A, Jacob J, Haegele P et al (1988) Controlled clinical trial for the treatment of patients with inoperable esophageal carcinoma: a study of EORTC Gastrointestinal Tract Cancer Cooperative Group. Rec Results Cancer Res 110–121Google Scholar
  88. Rudiger Siewert J, Feith M, Werner M, Stein HJ (2000) Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1, 002 consecutive patients. Ann Surg 232:353–361PubMedCrossRefGoogle Scholar
  89. Schroder W, Baldus SE, Monig SP et al (2002) Lymph node staging of esophageal squamous cell carcinoma in patients with and without neoadjuvant radiochemotherapy: histomorphologic analysis. World J Surg 26:584–587PubMedCrossRefGoogle Scholar
  90. Schurr PG, Yekebas EF, Kaifi JT et al (2006) Lymphatic spread and microinvolvement in adenocarcinoma of the esophago-gastric junction. J Surg Oncol 94:307–315PubMedCrossRefGoogle Scholar
  91. Sharpiro A, Robillard G (1950) The esophageal arteries. Ann Surg 131:171CrossRefGoogle Scholar
  92. Stahl M, Stuschke M, Lehmann N et al (2005) Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 23:2310–2317PubMedCrossRefGoogle Scholar
  93. Stahl M, Walz MK, Stuschke M et al (2009) Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. J Clin Oncol 27:851–856PubMedCrossRefGoogle Scholar
  94. Teniere P, Hay JM, Fingerhut A, Fagniez PL (1991) Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicenter controlled trial. French University Association for Surgical Research. Surg Gynecol Obstet 173:123–130PubMedGoogle Scholar
  95. Tepper J, Krasna MJ, Niedzwiecki D et al (2008) Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol 26:1086–1092PubMedCrossRefGoogle Scholar
  96. Thirion P, Michiels S, Le Maitre A (2007) Individual patient data-based meta: analysis assessing pre-operative chemotherapy in resectable oesophageal carcinoma. J Clin Oncol 25:200sGoogle Scholar
  97. Thompson WM (1983) Esophageal cancer. Int J Radiat Oncol Biol Phys 9:1533–1565PubMedCrossRefGoogle Scholar
  98. Tsutsui S, Moriguchi S, Morita M et al (1992) Multivariate analysis of postoperative complications after esophageal resection. Ann Thorac Surg 53:1052–1056PubMedCrossRefGoogle Scholar
  99. Tucker SL, Liu HH, Wang S et al (2006) Dose-volume modeling of the risk of postoperative pulmonary complications among esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery. Int J Radiat Oncol Biol Phys 66:754–761PubMedCrossRefGoogle Scholar
  100. Urba SG, Orringer MB, Turrisi A et al (2001) Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 19:305–313PubMedGoogle Scholar
  101. van Westreenen HL, Westerterp M, Bossuyt PM et al (2004) Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer. J Clin Oncol 22:3805–3812PubMedCrossRefGoogle Scholar
  102. Vesprini D, Ung Y, Kamra J (2006) The addition of 18-fluoodeoxglucose positron emission tomorgraphy (FDG-PET) to CT based radiotherapy planning of carcinoma of the esophagus decreases both the intra - and interobserver variability of GTV dlineation. Int J Radiat Oncol Biol Phys 66:S299–S300CrossRefGoogle Scholar
  103. Vuong T, Szego P, David M et al (2005) The safety and usefulness of high-dose-rate endoluminal brachytherapy as a boost in the treatment of patients with esophageal cancer with external beam radiation with or without chemotherapy. Int J Radiat Oncol Biol Phys 63:758–764PubMedCrossRefGoogle Scholar
  104. Walsh TN, Noonan N, Hollywood D et al (1996) A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 335:462–467PubMedCrossRefGoogle Scholar
  105. Wang SL, Liao Z, Vaporciyan AA et al (2006) Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery. Int J Radiat Oncol Biol Phys 64:692–699PubMedCrossRefGoogle Scholar
  106. Wang S, Liao Z, Wei X et al (2008) Association between systemic chemotherapy before chemoradiation and increased risk of treatment-related pneumonitis in esophageal cancer patients treated with definitive chemoradiotherapy. J Thorac Oncol 3:277–282PubMedCrossRefGoogle Scholar
  107. Weber WA, Ott K (2004) Imaging of esophageal and gastric cancer. Semin Oncol 31:530–541PubMedCrossRefGoogle Scholar
  108. Whittington R, Coia LR, Haller DG et al (1990) Adenocarcinoma of the esophagus and esophago-gastric junction: the effects of single and combined modalities on the survival and patterns of failure following treatment. Int J Radiat Oncol Biol Phys 19:593–603PubMedCrossRefGoogle Scholar
  109. Xiao ZF, Yang ZY, Miao YJ et al (2005) Influence of number of metastatic lymph nodes on survival of curative resected thoracic esophageal cancer patients and value of radiotherapy: report of 549 cases. Int J Radiat Oncol Biol Phys 62:82–90PubMedCrossRefGoogle Scholar
  110. Yang CS (1980) Research on esophageal cancer in China: a review. Cancer Res 40:2633–2644PubMedGoogle Scholar
  111. Ychou M, Boige V, Pignon JP et al (2011) Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J Clin Oncol 29:1715–1721PubMedCrossRefGoogle Scholar
  112. Zeccaro G, Rice T, Goldbloom J (1999) Endoscopic ultrasound can not determine suitability for esophagectomy after aggressive chemoradiotherapy for esophageal cancer. Am J Gasterinterol 94:906–912Google Scholar
  113. Zhong X, Yu J, Zhang B, et al (2007) Optimal SUV threshold of gross tumor volume delineation validated by pathologic examination in patients with esophaeal cancer. Intern J Radio Bio Phys 69:108–109Google Scholar
  114. Zobotto L, Toubouol E, Lerouge D (2005) Impact of CT, 18F-deoxyglucose positron emission tomography image fusion for conformal radiotherapy in esophageal carcinoma. Int J Radiat Oncol Biol Phys 63:340CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg  2011

Authors and Affiliations

  1. 1.Department of Radiation OncologyDuke University Medical CenterDurhamUSA
  2. 2.Department of Radiation OncologyDuke UniversityDurhamUSA

Personalised recommendations